High activity rhenium-186 hydroxyethylidene diphosphonate (HEDP) with autologous peripheral blood stem cell (PBSC) transplant: A novel treatment strategy in hormone refractory prostate cancer metastatic to bone.

Joe O'Sullivan, A.R. Norman, V.R. McCready, G. Flux, G. Cook, B. Johnson, J. Treleaven, D.P. Dearnaley

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)397S-397S
JournalJournal of Clinical Oncology
Publication statusPublished - 2004

Cite this